Search for: "Merck and Co,"
Results 181 - 200
of 1,277
Sort by Relevance
|
Sort by Date
25 Aug 2017, 3:00 am
Merck Sharp & Dohme, 796 F.3d 1038 (9th Cir. 2015). [read post]
26 Jul 2017, 12:26 pm
See In re Merck &Co., 800 F.2d 1091, 1097 (Fed. [read post]
12 Jul 2017, 3:50 am
John Stark Reed Readers undoubtedly are aware of the recent outbreak of ransomware incidents and the problems they present. [read post]
24 Jun 2017, 9:12 pm
Paul Jahn of Morrison & Foerster LLP; William Krovatin of Merck & Co., Inc.; and Richard Rainey of Covington & Burling LLP will explore the significant ramifications of the recent U.S. [read post]
16 Jun 2017, 9:44 am
This year's winners and technologies are: Merck & Co., Inc. in Greener Synthetic Pathways -- Letermovir: A Case Study in State-of-the-Art Approaches to Sustainable Commercial Manufacturing Processes in the Pharmaceutical Industry; Amgen Inc. and Bachem in Greener Reaction Conditions -- Green Process for Commercial Manufacture of Etelcalcetide Enabled by Improved Technology for Solid Phase Peptide Synthesis; The Dow Chemical Company and… [read post]
14 Jun 2017, 4:43 pm
It is probably worth noting with respect to the Merck Vioxx settlement that, as massive as it was, it was still not large enough to crack the top ten. [read post]
12 Jun 2017, 3:18 pm
This year's winners and technologies are: Merck & Co., Inc. in Greener Synthetic Pathways - Letermovir: A Case Study in State-of-the-Art Approaches to Sustainable Commercial Manufacturing Processes in the Pharmaceutical Industry Merck’s approach was to design an efficient synthesis as early as possible in the drug Letermovir’s process development. [read post]
6 Apr 2017, 1:35 pm
See Medicines Co. v. [read post]
3 Mar 2017, 7:25 am
The judge also cautioned that the purpose of the declarations in the present proceedings is different to the motivations for the declarations sought in Arrow Generics Limited v Merck & Co. [read post]
17 Feb 2017, 11:40 am
Merck & Co., Jan. 26, 2017, Maine Supreme Judicial Court More Blog Entries: Pit Bulls in Maine Dog Attack to Be Euthanized, Victim Mulling Civil Injury Lawsuit, Jan. 9, 2017, Bangor Defective Drug Lawyer Blog [read post]
9 Feb 2017, 3:15 am
(NYSE:BMY) and Kenilworth, NJ-based pharmaceutical firm Merck & Co. [read post]
8 Feb 2017, 3:09 am
Extraterritoriality – Trade Secrecy: Sino Legend (Zhangjiagang) Chemical Co. [read post]
5 Feb 2017, 6:45 am
Merck & Co. [read post]
16 Jan 2017, 5:44 pm
Extraterritoriality – Trade Secrecy: Sino Legend (Zhangjiagang) Chemical Co. [read post]
13 Jan 2017, 9:24 am
A declaration in these terms is described as an Arrow declaration, due to the form of relief sought in Arrow Generics Limited v Merck & Co. [read post]
6 Jan 2017, 2:01 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
5 Jan 2017, 2:15 am
On Thursday, December 15th, a subsidiary of Kenilworth, NJ-based pharmaceutical developer Merck & Co. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
22 Dec 2016, 8:35 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
16 Dec 2016, 4:44 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
